⌘K

Login Start Free

Home/Filings/4/0001282930-05-000002

4//SEC Filing

BENNETT J CLAUDE 4

Accession 0001282930-05-000002

CIK 0000882796other

View on SEC.gov Company Profile

Filed

Feb 8, 7:00 PM ET

Accepted

Feb 9, 1:11 PM ET

Size

17.7 KB

Accession

0001282930-05-000002

Insider Transaction Report

Form 4

Period: 2005-02-07

BIOCRYST PHARMACEUTICALS INCBCRX

BENNETT J CLAUDE

DirectorPresident

Transactions

Exercise/Conversion
Common Stock
2005-02-07$0.87/sh+1,219$1,061→ 19,469 total
Exercise/Conversion
Stock Option
2005-02-07$3.59/sh−636$2,283→ 402,669 total
Exercise: $3.59From: 2002-12-12Exp: 2012-12-11→ Common Stock (636 underlying)
Exercise/Conversion
Common Stock
2005-02-07$1.04/sh+104$108→ 18,250 total
Exercise/Conversion
Common Stock
2005-02-07$3.59/sh+636$2,283→ 17,387 total
Exercise/Conversion
Common Stock
2005-02-07$1.18/sh+759$896→ 18,146 total
Exercise/Conversion
Stock Option
2005-02-07$1.04/sh−104$108→ 401,806 total
Exercise: $1.04From: 2003-12-11Exp: 2013-12-10→ Common Stock (104 underlying)
Exercise/Conversion
Stock Option
2005-02-07$0.87/sh−1,219$1,061→ 400,587 total
Exercise: $0.87From: 2003-02-03Exp: 2013-02-03→ Common Stock (1,219 underlying)
Exercise/Conversion
Stock Option
2005-02-07$1.18/sh−759$896→ 401,910 total
Exercise: $1.18From: 2003-08-05Exp: 2013-08-04→ Common Stock (759 underlying)

Documents

1 file

4
edgar.xmlPrimary
PRIMARY DOCUMENT

Issuer

BIOCRYST PHARMACEUTICALS INC

CIK 0000882796

Entity typeother

Related Parties

1

filerCIK 0001198766

Filing Metadata

Form type: 4
Filed: Feb 8, 7:00 PM ET
Accepted: Feb 9, 1:11 PM ET
Size: 17.7 KB

View on SEC.gov